The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide

  • ID: 1084133
  • Report
  • Region: Global
  • 88 Pages
  • Research Facts Ltd
1 of 3


  • Abbott Laboratories
  • Alkermes, Inc.
  • AstraZeneca PLC
  • Dey, L.P.
  • MannKind Corporation
  • Oriel Therapeutics Inc.
  • MORE
Inhaled therapies have been used since ancient times and may have had their origins with the smoking of datura preparations in India 4,000 years ago. Inhalation became a mainstay of respiratory care in the 20th century. Due to the nature of the absorption within the lungs, inhaled pharmaceuticals tend to be very fast acting. Inhalation usually provides a very fast rise of the level of the pharmaceutical in the blood, when compared to other delivery techniques, such as oral or transdermal delivery. For example, albuterol is a bronchodialator which acts rapidly when inhaled to treat an asthma attack, a condition for which treatment with a solid oral dosage form may be too slow. In fact, inhaled medication is the commonest form of therapy for acute and chronic asthma and for other conditions associated with airflow limitation (obstructive bronchitis, emphysema, cystic fibrosis).

There are many pharmaceutical companies worldwide. This report profiles the Top 40 developers of inhaled pharmaceuticals. These are the companies with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that can compete effectively in global markets.

Profile information for each company in The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide typically includes:

- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Address
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Ownership, Products, Therapeutic Areas, Foreign Trade, Location Status, Year Established, Number of Employees and Turnover.

Report Target Market:

1) Pharmaceutical Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Drug Delivery Companies

This report is perfect for speciality drug delivery companies with inhalation drug delivery technologies and expertise.

3) Manufacturers Of Inhalation Devices

The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide is ideal for manufacturers of inhalation devices such as metered-dose inhalers to identify new potential customers.

4) Contract Services Providers

This report is very useful to contract services providers for pharmaceutical, biotechnology and medical device companies that bring new inhalation products to market.

Note: Most people will be aware of some of the major developers of inhaled pharmaceuticals such as AstraZeneca PLC, but this report looks at all 40 of the top companies - companies like - Dey, L.P. - a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine and the U.S. leader in sales of nebulized respiratory medication.

Report data field structure is as follows:

Company Name
Mailing Address

Street Address
Parent Company Name
Year Established
Number of Employees
Key Executives
Company Description
Therapeutic Areas
Turnover €m
Foreign Trade
Location Status

Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts’ customers include most of the world’s major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Roche, Abbott, Quintiles, Johnson & Johnson, Wyeth, GlaxoSmithKline, Medtronic, Siemens Medical, Philips Healthcare, Thermo Fisher Scientific, GE Healthcare, Ipsen, Edwards Lifesciences etc..

Research Facts’ reports help you make informed decisions about the markets and organisations that affect your business.

- Learn more about your target markets and target companies
- Top level research on all major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations


Hardcopy: Bound report, A4 format, 88 pages

Electronic: pdf Version, A4 format, 88 pages

Author: The scientific advisor on this report was Katie Ryan. Katie has degrees in physiology and medicine from Trinity College Dublin and is a full-time researcher there in the School of Medicine.

Inhaled Pharmaceuticals
Note: Product cover images may vary from those shown
2 of 3


3 of 3
Abbott Laboratories
Actelion Pharmaceuticals Ltd
Akela Pharma Inc.
Alexza Pharmaceuticals
Alkermes, Inc.
Amphastar Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc.
Aradigm Corporation
Arrow Generics Ltd
AstraZeneca PLC
Axentis Pharma AG
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
Cipla Ltd.
Dey, L.P.
Epigenesis Pharmaceuticals, LLC
Forest Pharmaceuticals, Inc.
GlaxoSmithKline plc
Hovione FarmaCiencia SA
Kamada Ltd.
MannKind Corporation
Map Pharmaceuticals
Meda AB
MicroDose Therapeutx, Inc.
Minrad International, Inc.
Nephron Pharmaceuticals Corporation
Novartis International AG
Nycomed International Management GmbH
Oriel Therapeutics Inc.
Pari Pharma GmbH
Respirics Inc.
Schering-Plough Corporation
Sepracor Inc.
Teva Specialty Pharmaceuticals LLC
Topigen Pharmaceuticals Inc.
Transave, Inc.
United Therapeutics Corporation
Vectura Group plc
YM BioSciences Inc.
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown